Walkers Begin 60 Mile Trek During Susan G. Komen 3-DayA sea of pink will be moving through the streets of North Texas. The Susan G. Komen Dallas 3-Day started Friday and 'runs' through Sunday.
Blood Test May Help Predict Which Breast Cancers Will RecurA blood test five years after breast cancer treatment helped identify some women who were more likely to relapse, long before a lump or other signs appeared, a preliminary study found.
Crowdsourcing Effort Takes Aim At Deadliest Breast CancersForget the pink ribbons. Spitting in a tube for science is what unites a growing group of breast cancer patients taking part in a unique project to advance treatment for the deadliest form of the disease.
American Cancer Society Says Start Mammograms At 45, Not 40New mammogram advice from the American Cancer Society says most women should start annual screenings at age 45 instead of 40.
Komen Race Paints Plano PinkThousands packed the streets of Plano Saturday morning for the annual Komen Race for the Cure. Komen headquarters is based in Dallas. The race is one of the nation's largest events for the breast cancer research group.
Husband & Wife Endure After Both Diagnosed With CancerOver the course of four decades a marriage that lasts endures a lot—and shares even more. Marilyn and her husband, Steve, have redefined togetherness: but, not in the way that either of them would have imagined.
Study Ties New Gene To Major Breast Cancer Risk It's long been known that faulty BRCA genes greatly raise the risk for breast cancer. Now scientists say a more recently identified, less common gene can do the same.
Doctors Recommend Genetic Retesting For Breast CancerOver the past decade, the phrases ‘BRCA 1’ and ‘BRCA 2’ went mainstream as genetic testing to assess breast cancer risk became common. But, now, doctors are telling patients whose tests were negative to get retested.
North Texas Hospital Performing Groundbreaking Breast Cancer Research A North Texas hospital is performing groundbreaking breast cancer research. Doctors are using cutting edge medical technology to customize treatment.
New Drug, Study Method Shows Breast Cancer Promise A novel way to speed the testing of cancer drugs and quickly separate winners from duds has yielded its first big result: an experimental medicine that shows promise against a hard-to-treat form of breast cancer.
Thousands Walk Texas In Susan G. Komen 3-DayFor eight years, D’Lyn Biggs has walked the Susan G. Komen 3-Day. She’s logged more than 400 miles, and along with a team of supporters has raised more than $800,000 for the cause.
Group: Breast Cancer Awareness Is More Than Pink RibbonsThis month many people are thinking ‘pink’ for breast cancer awareness, but for survivors, the fight is anything but pretty. Now local survivors have taken to the internet to paint another picture of breast cancer.
Gene Flaws Common In Blacks With Breast Cancer Gene flaws that raise the risk of breast cancer are surprisingly common in black women with the disease, according to the first comprehensive testing in this racial group.
FDA Approves New Targeted Breast Cancer DrugThe Food and Drug Administration has approved a first-of-a-kind breast cancer medication that targets tumor cells while sparing healthy ones.